Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Clinical effects and safety of edaravone in treatment of acute ischaemic stroke: A meta‐analysis of randomized controlled trials

Published:2021-02-27 Issue:4 Volume:46 Page:907-917
ISSN:0269-4727
Container-title:Journal of Clinical Pharmacy and Therapeutics
language:en
Short-container-title:J Clin Pharm Ther

Author:

Chen Chongyue¹,Li Mingkai²,Lin Liling³,Chen Shuying³,Chen Yongru¹,Hong Liekai⁴^ORCID

Affiliation:

1. Department of Emergency Intensive Care Unit The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China

2. Zhongshan School of Medicine Sun Yat‐Sen University Guangzhou Guangdong China

3. Department of Neurology The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China

4. Department of Cardiovascular The First Affiliated Hospital of Shantou University Medical College Shantou Guangdong China

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jcpt.13392

Reference30 articles.

1. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of the management of high-risk population

2. Chinese Stroke Association guidelines for clinical management of cerebrovascular disorders: executive summary and 2019 update of clinical management of ischaemic cerebrovascular diseases

3. Neuroprotection and the Ischemic Cascade

4. Drug Repurposing: Promises of Edaravone Target Drug in Traumatic Brain Injury

5. Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety, tolerability, and pharmacokinetic of HY0721 in Chinese healthy subjects: A first-in-human randomized, double-blind, placebo-controlled dose escalation phase I study;European Journal of Pharmaceutical Sciences;2024-09

2. Edaravone: A Possible Treatment for Acute Lung Injury;International Journal of General Medicine;2024-09

3. Edaravone for the Treatment of Motor Neurone Disease: A Critical Review of Approved and Alternative Formulations against a Proposed Quality Target Product Profile;Pharmaceutics;2024-07-26

4. New Perspectives in Neuroprotection for Ischemic Stroke;Neuroscience;2024-07

5. Effect of food on oral pharmacokinetics of edaravone coamorphous dispersion containing bile salts as coformers – Part II;Annales Pharmaceutiques Françaises;2024-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3